GlassScriptPhysician profile
Andrew C Potts
NPI 1942725593
$1,097.80
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $444 · 2022: $654.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241.71 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $128.25 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $120.25 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.29 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $78.21 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $67.26 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $62.89 | 2021-2022 | |
| Lundbeck LLC | $51.12 | 2021-2022 | |
| Bausch Health US, LLC | $48.98 | 2022 | |
| Almatica Pharma LLC | $44.54 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $40.10 | 2021 | |
| Jazz Pharmaceuticals INC. | $39.64 | 2021-2022 | |
| Alkermes, INC. | $37.06 | 2021-2022 | |
| Corium, LLC | $22.36 | 2022 | |
| Adlon Therapeutics L.P. | $16.94 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.20 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.